Cells | Free Full-Text | Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model
Frontiers | CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
Functional multi-omics reveals genetic and pharmacologic regulation of surface CD38 in multiple myeloma | bioRxiv
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formatio
New Strategies for Targeting CD38 in Multiple Myeloma Take Root
International Clinical Cytometry Society
Expression of CD38 in normal and malignant plasma cells.... | Download Scientific Diagram
ePosters - Inecalcitol Stimulates CD38 Expression in Multiple Myeloma and Acute Myeloid Leukemia Cell Lines
International Clinical Cytometry Society
Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes | SpringerLink
CD38 - Wikipedia
CD38, A Target for Immunotherapeutic Approaches in Cancer
Cells | Free Full-Text | The Many Facets of CD38 in Lymphoma: From Tumor–Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy
Pre-treatment CD38-positive regulatory T cells affect the durable response to daratumumab in relapsed/refractory multiple myeloma patients | Haematologica
Multiple myeloma with t(11;14)‐associated immature phenotype has lower CD38 expression and higher BCL2 dependence - Kitadate - 2021 - Cancer Science - Wiley Online Library
Detect CD38 expression during anti-CD38 therapy – Caltag Medsystems
Double CD38−/CD138− negative multiple myeloma - ScienceDirect
Pre-treatment CD38-positive regulatory T cells affect the durable response to daratumumab in relapsed/refractory multiple myeloma patients | Haematologica
Blood and Hematology - CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance MM cells express high levels of CD38, while CD38 is expressed at relatively low levels on
CD38, A Target for Immunotherapeutic Approaches in Cancer
Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab | Leukemia
A Guide to Plasma Cell Markers | Biocompare: The Buyer's Guide for Life Scientists
CD38 expression and function in NK cells. (A) Role of CD38 in the... | Download Scientific Diagram
